Chen Xin (辰欣)辰欣
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 辰欣药业股份有限公司Chinese legal name: 辰欣药业股份有限公司
主要成分Active Ingredients
- 噻氯匹定Sailv Piding
药物知识说明
噻氯匹定是一种在国家药监局注册认定的药品。该药品含有噻氯匹定-803a1f33等成分。
该药品关联的活性成分包括：噻氯匹定Sailv Piding。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：辰欣药业股份有限公司Chinese legal name: 辰欣药业股份有限公司。
您可以探索含有相同成分的其他药品：噻氯匹定-803a1f33成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 辰欣) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 噻氯匹定Sailv Piding.
Manufacturers recorded for this product: 辰欣药业股份有限公司Chinese legal name: 辰欣药业股份有限公司.
Explore other medicines containing the same ingredient: 噻氯匹定 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 辰欣Recorded Chinese name: 辰欣
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 0.125g0.125 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 辰欣药业股份有限公司Chinese legal name: 辰欣药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10970138
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10970138
Manufacturer
Chinese legal name: 辰欣药业股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H10970138
生产企业
辰欣药业股份有限公司(国产)
适应症
本品预防和治疗因血小板高聚集状态引起的心、脑及其他动脉的循环障碍性疾患。
用法用量
口服：一日1次，一次1粒(0.25g);就餐时服用以减少胃肠道反应。
不良反应
1.偶见轻微胃肠道反应。
2.罕见的反应有:恶心、腹泻、皮疹、瘀斑、齿龈出血、白细胞减少、粒细胞缺乏、胆汁阻塞性黄疸、肝功能损害。
3.以上不良反应均在停药后消失。
禁忌
1.血友病或其它出血性疾病患者、粒细胞或血小板减少患者、溃疡病及活动性出血患者均不应使用此药。
2.严重的肝功能损害患者，由于凝血因子合成障碍，往往增加出血的危险，故本品不宜使用。
3.对本品过敏者。
4.白细胞总数减少、血小板减少或有粒细胞减少病史者。
注意事项
1.用药最初三个月内，须每二周检查白细胞和血小板计数，当发现计数减低时，应停药。
2.在任何手术和动脉插管或输注之前（7日），应停用。使用本品的病人须手术时，应在术前尽可能告知外科医生。
贮藏
遮光，密闭保存。
规格
0.125g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.